AXL limits the mobilization of cholesterol to regulate dendritic cell maturation and the immunogenic response to cancer
Meriem Belabed(Icahn School of Medicine at Mount Sinai), Miriam Mérad(Icahn School of Medicine at Mount Sinai), Kristen J. Radford(Translational Research Institute), Ante Peros(Icahn School of Medicine at Mount Sinai), C. Matthias Wilk(Icahn School of Medicine at Mount Sinai), Leanna Troncoso(Icahn School of Medicine at Mount Sinai), Sourav Ghosh(Yale University), Amanda M. Reid(Icahn School of Medicine at Mount Sinai), Matthew D. Park(Icahn School of Medicine at Mount Sinai), Laurent Yvan‐Charvet(Inserm), Daniel J. Puleston(Bloomberg (United States)), Jessica Le Bérichel(Icahn School of Medicine at Mount Sinai), Sreekumar Balan(Icahn School of Medicine at Mount Sinai), Nina Bhardwaj(Mount Sinai Hospital), Thomas U. Marron(Icahn School of Medicine at Mount Sinai), Steven T. Chen(Icahn School of Medicine at Mount Sinai), Cédric M. Blouin(Centre National de la Recherche Scientifique), Nelson M. LaMarche(Icahn School of Medicine at Mount Sinai), Brian D. Brown(Icahn School of Medicine at Mount Sinai), Christophe Lamaze(Centre National de la Recherche Scientifique), Chang Moon(Icahn School of Medicine at Mount Sinai), Carla V. Rothlin(Yale University), Jesse Boumelha(The Francis Crick Institute), Raphaël Mattiuz(Icahn School of Medicine at Mount Sinai), Camillia S. Azimi(Icahn School of Medicine at Mount Sinai), Angelo Amabile(Icahn School of Medicine at Mount Sinai)
Cited by 7
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k